However, considering the possibility that the ERK pathway may be the major downstream signaling pathway activated downstream of FGFR3 as discussed in the previous section, this pathway may play a more dominant role in inducing MYC protein accumulation in bladder cancer with aberrantly activated FGFR3. The gene discussed is FGFR3; the disease is urinary bladder cancer.